SAN JOSE, Calif. — Complete Genomics, a U.S.-based provider of end-to-end DNA sequencing platforms, reagents and software, today announced the appointment of entrepreneur, investor and film producer Lauren Selig to its board of directors. Selig is the founder of Shake and Bake Productions and leads an investment fund focused on companies across artificial intelligence, space, biotechnology, media and other [...]

Veteran Pharmacogenomics Leader and Former St. Jude CEO to Guide BioSkryb's Next Phase of Growth DURHAM, N.C. -- BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb's Board of Directors and as Chair of [...]

Appointment strengthens Element's board as the company continues to advance the future of precision medicine and AI-enabled drug discovery; executive promotions reflect growing maturity of the company SAN DIEGO, CA — Element Biosciences, Inc. today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors. Dr. Dolsten brings more than 35 years of leadership [...]

Amsbio has launched a range of synthetic cell mimic products that eliminate the variability, fragility, and operational inefficiency inherent in traditional flow cytometry biological and polystyrene bead controls. Researchers in pharmaceutical companies, biotechnology firms, CRO’s, clinical diagnostics and academic centres have long sought access to mass-produced cell mimics that contain rare biomarkers and are stable over the long [...]

Collaboration embeds evidence-grounded agentic AI into scientific workflows across Syneos Health, accelerating research while strengthening scientific rigor, consistency, and sponsor value LONDON -- Causaly, the agentic AI platform purpose-built for life sciences research and development, today announced a strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization. The collaboration will help establish a [...]

The Board of Directors of BICO Group AB today announces the appointment of Anders Fogelberg, currently Chief Commercial Officer, as President and CEO, effective September 1, 2026. The Board of Directors have, in a constructive dialogue together with the current President and CEO, Maria Forss, concluded that the time is right for a leadership change. [...]

WASHINGTON -- Xylem Inc. (NYSE: XYL), a leading global water solutions company, today announced that Andrea van der Berg has been appointed Executive Vice President and Chief Financial Officer, effective September 1, 2026. She will report to President and Chief Executive Officer Matthew Pine and join Xylem’s Executive Leadership Team. Van der Berg succeeds William [...]

Uppsala, Sweden – Navinci Diagnostics AB today announces that the company has initiated a collaboration with BrainZell to explore the use of Navinci’s in situ Proximity Ligation Assay technology in human brain organoid models to support relevant studies of biology and drug response. The collaboration aims to evaluate how functional spatial readouts can be applied [...]

Laboratories rely on accurate, repeatable and traceable test results to support product quality, regulatory compliance and operational safety. Routine verification of laboratory instruments plays a vital role in maintaining confidence in those results. Stanhope-Seta is pleased to announce the expansion of its UKAS ISO 17034 accreditation, with the addition of five new Certified Reference Materials (CRMs) [...]

Purpose-engineered cell-like controls deliver improved positive/negative separation, broad species compatibility, and a liquid, non-biohazardous ready-to-use format EMERYVILLE, Calif. -- Slingshot Bio, Inc., a leader in precision cell mimic controls for flow cytometry, today announced the commercial launch of ViaComp® Ultra Amine, a next-generation compensation control designed for amine-reactive viability dyes and fluorophore-conjugated antibody panels in [...]